bayer

AgBio startup celebrates crop science expansion in Durham, partnership with Bayer

Posted by WRAL TechWire | Jan 20, 2023

More than 100 people gathered at Oerth Bio, an agricultural biotechnology company in downtown Durham, to hear about a new collaboration between Oerth and Bayer, a global enterprise focused on health care and nutrition, and to celebrate Oerth’s facilities expansion.

Inside a deal: Startup Tavros Therapeutics’ potential $403M collaboration

Posted by WRAL TechWire | Oct 14, 2022

Durham-based biotechnology startup Tavros Therapeutics will partner with Bayer AG subsidiary Vividion Therapeutics to find new targets and treatments for cancer. Here’s a detailed look at the deal.

RTP startup Tavros Therapeutics strikes $430M deal with Bayer subsidiary

Posted by Jason Parker | Oct 12, 2022

RTP oncology firm Tavros Therapeutics has entered into a collaboration with a wholly-owned subsidiary of Bayer AG.

SAS, Bayer, BASF, Novozymes team up with NCSU for plant science effort

Posted by WRAL TechWire | Apr 19, 2022

Bayer, BASF, SAS and Novozymes have agreed to collaborate with NC State University researchers at the new Plant Sciences Building, a leading-edge facility at the heart of the university’s N.C. Plant Sciences Initiative (N.C. PSI), an effort that fosters interdisciplinary, team-based work between academia, industry, government, and growers to solve the most perplexing plant science challenges locally and globally.

Bayer selling its Cary-based pest control business for $2.6B

Posted by WRAL TechWire | Mar 10, 2022

CARY – German chemical and health care company Bayer said Thursday it is selling a U.S.-based pest control business to private equity firm Cinven for $2.6 billion. The business is based in Cary and has some 800 employees. “This divestment represents a very attractive purchase price and allows us...

AskBio to be hiring ‘across the board,’ CEO says after $4B deal with Bayer

Posted by WRAL News | Oct 28, 2020

After sale to Bayer, gene therapy firm AskBio plans expansion and hiring, says its CEO in an exclusive interview with WRAL TechWire.

Inside the $4B AskBio deal, the third largest buyout ever for an NC bioscience firm

Posted by WRAL TechWire | Oct 27, 2020

Asklepios BioPharmaceutical (AskBio), a pioneering gene therapy company born in Chapel Hill 19 years ago and supported in its early years by the North Carolina Biotechnology Center, will be acquired by Bayer AG, Here’s a look at the deal and the company’s history.

AskBio exec: Gene editing firm chose $4B Bayer offer over other firms, also going public

Posted by WRAL TechWire | Oct 26, 2020

Bayer’s $2 billion upfront price plus the same amount offered based on milestone achievements wasn’t the only financial windfall leaders at AskBio were considering before agreeing to Bayer’s terms, says a company exec.